Cover Image

Renal outcomes of STOP-IgAN trial patients in relation to baseline histology (MEST-C scores)

The Oxford classification of IgA nephropathy (IgAN) defines histologic criteria (MEST-C) that provide prognostic information based on the kidney biopsy. There are few data on the predictive impact of this classification in randomized clinical trial settings.

Saved in:
Bibliographic Details
Main Authors: Schimpf, Judith Isabel (Author) , Klein, Till (Author) , Fitzner, Christina (Author) , Eitner, Frank (Author) , Porubský, Štefan (Author) , Hilgers, Ralf-Dieter (Author) , Flöge, Jürgen (Author) , Groene, Hermann-Josef (Author) , Rauen, Thomas (Author)
Format: Article (Journal)
Language:English
Published: 2018
In: BMC nephrology
Year: 2018, Volume: 19, Pages: 1-11
ISSN:1471-2369
DOI:10.1186/s12882-018-1128-6
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s12882-018-1128-6
Get full text
Author Notes:Judith Isabel Schimpf, Till Klein, Christina Fitzner, Frank Eitner, Stefan Porubsky, Ralf-Dieter Hilgers, Jürgen Floege, Hermann-Josef Groene and Thomas Rauen
Description
Summary:The Oxford classification of IgA nephropathy (IgAN) defines histologic criteria (MEST-C) that provide prognostic information based on the kidney biopsy. There are few data on the predictive impact of this classification in randomized clinical trial settings.
Item Description:Gesehen am 12.03.2020
Physical Description:Online Resource
ISSN:1471-2369
DOI:10.1186/s12882-018-1128-6

Similar Items